Access product information, patient resources, and prior authorization checklists for many commonly prescribed acute and preventive migraine treatments. These resources can help you better understand your medication and prepare for the insurance approval process.
Product Information and Prior Authorization Checklists
Ubrogepant (Ubrelvy)
Uses: Acute treatment
Zavegepant (Zavzpret)
Uses: Acute treatment
Atogepant (Qulipta)
Uses: Prevention
Eptinezumab (Vyepti)
Uses: Prevention
Erenumab (Aimovig)
Uses: Prevention
Fremanezumab (Ajovy)
Uses: Prevention
Galcanezumab (Emgality)
Uses: Prevention
Healthy Blue NC Prior Authorization
(Optum Rx Prior Authorization)
Insurance Payer Engagement
UnitedHealthcare announces Gold Card program for some prior authorizations
UnitedHealthcare (UHC) has announced it will launch a Gold Card program October 1, 2024 intended to ease some prior authorizations. Practices that qualify will receive a streamlined prior authorization process for certain medical, behavioral, and mental health services.
While programs that reduce administrative burden may improve access to care for some patients, the National Headache Foundation continues to support broader reforms that address prior authorization delays, step therapy requirements, and other barriers to timely access to evidence-based headache and migraine care for all patients